NICE recommends Idorsia’s chronic insomnia treatment for UK patients
The therapy will be available to patients who have insomnia multiple times a week, do not respond to CBTi, and whose wakeful day is severely impacted.
The therapy will be available to patients who have insomnia multiple times a week, do not respond to CBTi, and whose wakeful day is severely impacted.
What's Your Reaction?
